Processa Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity, Disclosure: Schedule of Stock Option Activity (Tables)

3 Months Ended

Mar. 31, 2017

	Number of Options	Weighted Average Exercise Price	Weighted Average Remaining Life (Years)
Balance, December 31, 2016	269,500	$ 1.88	2.04
Granted	--	$ --	--
Exercised	--	$ --	--
Cancelled	(22,000)	$ 1.64	--
Balance, March 31, 2017	247,500	$ 1.90	1.95
Exercisable, March 31, 2017	247,500	$ 1.90	1.95